首页> 外文期刊>American Journal of Physiology >Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis
【24h】

Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis

机译:加速受体脱落抑制肾损伤分子-1(Kim-1)介导的兴奋性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Efficient clearance of apo-ptotic cells (efferocytosis) prevents inflammation and permits repair following tissue injury. Kidney injury molecule-1 (KIM-1) is a receptor for phosphatidylserine, an "eat-me" signal exposed on the surface of apoptotic cells that marks them for phagocytic clearance. KEVI-1 is upregulated on proximal tubule epithelial cells (PTECs) during isch-emic acute kidney injury (AKI), enabling efferocytosis by surviving PTECs. KIM-1 is spontaneously cleaved at its ectodomain region to generate a soluble fragment that serves a sensitive and specific biomarker for AKI, but the biological relevance of KIM-1 shedding is unknown. Here, we sought to determine how KIM-1 shedding might regulate efferocytosis. Using cells that endogenously and exogenously express KIM-1, we found that hydrogen peroxide-mediated oxidative injury or PMA treatment accelerated KIM-1 shedding in a dose-dependent manner. KIM-1 shedding was also accelerated when apoptotic cells were added. Accelerated shedding or the presence of excess soluble KIM-1 in the extracellular milieu significantly inhibited efferocytosis. We also identified that TNF-alpha-converting enzyme (TACE or ADAM17) mediates both the spontaneous and PMA-accelerated shedding of KIM-1. While accelerated shedding inhibited efferocytosis, we found that spontaneous KIM-1 cleavage does not affect the phagocytic efficiency of PTECs. Our results suggest that KIM-1 shedding is accelerated by worsening cellular injury, and excess soluble KIM-1 competitively inhibits efferocytosis. These findings may be important in AKI when there is severe cellular injury.
机译:高效间隙的Apo-pootic细胞(效力症)可防止炎症并允许在组织损伤后修复。肾损伤分子-1(Kim-1)是磷脂酰丝氨酸的受体,暴露在凋亡细胞表面上的“吃掉”信号,标记为吞噬清除。在ISCH-EMIC急性肾损伤(AKI)期间,在近端小管上皮细胞(PTEC)上上调Kevi-1,通过幸存PTECS来实现效力细胞菌。 Kim-1在其外立骨髓区域上自发地切割以产生可溶性片段,该片段用于AKI的敏感和特异性生物标志物,但Kim-1脱落的生物学相关性未知。在这里,我们试图确定Kim-1脱落如何调节患有效率症。使用内源性和外源表达Kim-1的细胞,我们发现过氧化氢介导的氧化损伤或PMA处理以剂量依赖性方式加速Kim-1脱落。当加入凋亡细胞时,Kim-1脱落也加速。加速脱落或多余可溶性Kim-1在细胞外的Milieu中的存在显着抑制了癫痫细胞增多症。我们还发现TNF-α-转换酶(TACE或ADAM17)介导自发性和PMA加速的KIM-1的脱落。虽然加速脱落抑制效力细胞症,但我们发现自发的Kim-1裂解不会影响PTEC的吞噬效率。我们的研究结果表明,通过恶化细胞损伤加速Kim-1脱落,多余的可溶性Kim-1竞争性抑制癫痫细胞症。当细胞损伤严重时,这些发现可能在AKI中重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号